Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA

被引：0
作者：
Michael P. Barry
Elizabeth J. Austin
Elenore P. Bhatraju
Sara N. Glick
Joanne D. Stekler
Elyse L. Tung
Ryan N. Hansen
Emily C. Williams
Alexander J. Gojic
Eleanor I. Pickering
Judith I. Tsui
机构：
[1] University of Washington,Department of Epidemiology, Hans Rosling Center, School of Public Health
[2] Public Health – Seattle and King County,HIV/STD Program
[3] University of Washington,Department of Health Systems and Population Health, Hans Rosling Center, School of Public Health
[4] University of Washington,Division of General Internal Medicine, Department of Medicine, Harborview Medical Center
[5] University of Washington,Division of Allergy and Infectious Diseases
[6] University of Washington,Department of Global Health, Hans Rosling Center, School of Public Health
[7] Kelley-Ross Pharmacy Group,Department of Pharmacy
[8] University of Washington,Center of Innovation for Veteran
[9] VA Puget Sound,Centered and Value
[10] Yale School of Public Health,Driven Care, Health Services Research and Development
来源：
Harm Reduction Journal | / 19卷
关键词：
People who inject drugs; HIV; Pre-exposure prophylaxis; Behavioral determinants; Substance use; Hepatitis C;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 237 条
[1]  
Alpren C(2020)Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs—Massachusetts, 2015–2018 Am J Public Health 110 37-44
[2]  
Dawson EL(2019)Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs—Seattle, Washington, 2018 Morbity Mortal Wkly Rep 68 344-349
[3]  
John B(2019)Ending the HIV epidemic: a plan for the United States JAMA 321 844-S249
[4]  
Cranston K(2020)Responding to outbreaks of human immunodeficiency virus among persons who inject drugs—United States, 2016–2019: perspectives on recent experience and lessons learned J Infect Dis 222 S239-239
[5]  
Panneer N(2016)HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015 N Engl J Med 375 229-410
[6]  
Fukuda HD(2012)Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 399-2599
[7]  
Golden MR(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-94
[8]  
Lechtenberg R(2012)Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study AIDS Patient Care STDS 26 87-1293
[9]  
Glick SN(2020)Low PrEP awareness and use among people who inject drugs, San Francisco, 2018 AIDS Behav 24 1290-824
[10]  
Dombrowski J(2020)The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review AIDS Behav 29 819-155
12345678910